SEC Form 4 · accession 0001127602-18-036005
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 12:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2018 | S | 300 | $126.24 | D | 307,193 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.25 | D | 307,093 | D | |
| Common Stock | Dec 10, 2018 | S | 7 | $126.26 | D | 307,086 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.27 | D | 306,986 | D | |
| Common Stock | Dec 10, 2018 | S | 500 | $126.28 | D | 306,486 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.31 | D | 306,286 | D | |
| Common Stock | Dec 10, 2018 | S | 300 | $126.32 | D | 305,986 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.34 | D | 305,786 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.35 | D | 305,686 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.36 | D | 305,586 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.375 | D | 305,486 | D | |
| Common Stock | Dec 10, 2018 | S | 8 | $126.39 | D | 305,478 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.405 | D | 305,378 | D | |
| Common Stock | Dec 10, 2018 | S | 500 | $126.44 | D | 304,878 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.455 | D | 304,778 | D | |
| Common Stock | Dec 10, 2018 | S | 493 | $126.48 | D | 304,285 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.49 | D | 304,085 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.50 | D | 303,985 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.53 | D | 303,885 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.565 | D | 303,785 | D | |
| Common Stock | Dec 10, 2018 | S | 300 | $126.58 | D | 303,485 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.585 | D | 303,385 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.61 | D | 303,285 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.615 | D | 303,185 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.